Jupiter Orphan Therapeutics, Inc. Strengthens its Advisory Boards

JUPITER, Fla., Sept. 13, 2016 /PRNewswire/ -- Jupiter Orphan Therapeutics, Inc. (JOT) today announced that Professor Li-Huei Tsai, Ph.D. and Professor Scott Turner, Ph.D. have joined the JOT Scientific Advisory Board, and Robert Hahl, Ph.D. has joined the JOT Business Advisor Board.

Logo - http://photos.prnewswire.com/prnh/20160912/406582LOGO

"It is a true honor to have these world renowned scientists joining JOT. This is also a statement and verification to the science and pipeline we have developed in a very short period of time," stated JOT CEO, Christer Rosén. 

Professor Li-Huei Tsai, Ph.D. is a Scientific Advisor at Jupiter Orphan Therapeutics. She is currently the Director of the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology, a Picower Professor of Neuroscience, and an Associate Member of the Broad Institute. She obtained Ph.D. from University of Texas Southwestern Medical Centre in Dallas and postdoctoral training at Cold Spring Harbor Laboratories and Massachusetts General Hospital. Dr. Tsai became Assistant Professor of Pathology at Harvard Medical School and was promoted to tenure Professor at Harvard in 2002. She relocated to Massachusetts Institute of Technology in 2006. She was an Investigator of the Howard Hughes Medical Institute from 1997 to 2013. Dr. Tsai is also a Fellow of the American Association for the Advancement of Science, a member of the National Academy of Medicine, and an Academician of the Academia Sinica in Taiwan.        

Scott Turner, MD, Ph.D. is a Scientific Advisor at Jupiter Orphan Therapeutics. He is currently the Professor of Neurology and Director of the Memory Disorders Program at Georgetown University Medical Center, Washington, DC. Previously, he was Chief of the Neurology Service at the VA Ann Arbor Healthcare System and Associate Professor and Associate Chair in the Department of Neurology, University of Michigan. Turner obtained his MD and PhD degrees from Emory University, Atlanta, and completed his internship, residency, and fellowship at the University of Pennsylvania, Philadelphia. He was recruited to Georgetown in 2008. Dr. Turner has received numerous prestigious awards, including a fellowship from the Howard Hughes Medical Institute and a Paul Beeson Scholarship. Dr. Turner serves as a reviewer for granting agencies and biomedical journals, has published more than seventy peer-reviewed paper, editorials, and book chapters, as well as lectures widely. He is board-certified in Psychiatry and Neurology.

Robert W Hahl, Ph.D. is a Business Advisor at Jupiter Orphan Therapeutics. He obtained a Ph.D. in 1989 from Harvard University in Organic Chemistry. Prior to obtaining an advanced degree he worked as a research chemist at Merck and Co. Robert obtained his J.D. at the George Washington University Law School in 1993. Robert is admitted to practice before the United States Patent and Trademark Office, the Courts of the Commonwealth of Virginia, the District of Columbia and the Court of Appeals for the Federal Circuit (CAFC). Robert Hahl is a registered patent attorney and has extensive experience in chemical, pharmaceutical and biotechnology patents.

Visit www.jupiterorphan.com for additional company information.

Media contact:
Christer Rosén, Jupiter Orphan Therapeutics - +1 561 308-7780 
Email

SOURCE Jupiter Orphan Therapeutics, Inc.

Related Links

http://www.jupiterorphan.com